Peter Langmann
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
-
- HIV/AIDS drug development and treatment 13
-
- Analytical Methods in Pharmaceuticals 8
- Co-authors
- Hartwig Klinker (32 shared papers)Michael Zilly (19 shared papers)Benedikt Weißbrich (8 shared papers)Ralf Winzer (10 shared papers)Steffen Desch (5 shared papers)Franz Tollmann (2 shared papers)Werner Heinz (5 shared papers)Erik Arne Richter (3 shared papers)
In The Last Decade
Peter Langmann
39 papers receiving 590 citations
Peers
Comparison fields: 5 of 54
- Pharmacology 100
- Analytical Chemistry 116
- Infectious Diseases 187
- Emergency Medicine 57
- Virology 19
Countries citing papers authored by Peter Langmann
This map shows the geographic impact of Peter Langmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Langmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Langmann more than expected).
Fields of papers citing papers by Peter Langmann
This network shows the impact of papers produced by Peter Langmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Langmann. The network helps show where Peter Langmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Langmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 57 | |
| 2 | No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment. | 2003 | 56 |
| 3 | 2009 | 38 | |
| 4 | 2001 | 37 | |
| 5 | 2010 | 37 | |
| 6 | 1999 | 36 | |
| 7 | Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients. | 2002 | 35 |
| 8 | 2005 | 25 | |
| 9 | 1998 | 24 | |
| 10 | 1996 | 22 | |
| 11 | 2002 | 21 | |
| 12 | Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir. | 2000 | 18 |
| 13 | 2004 | 18 | |
| 14 | 2004 | 18 | |
| 15 | Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin. | 2002 | 17 |
| 16 | 2005 | 17 | |
| 17 | 2005 | 17 | |
| 18 | 1996 | 12 | |
| 19 | Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis. | 2000 | 12 |
| 20 | Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups. | 2003 | 12 |
About Peter Langmann
Peter Langmann is a scholar working on Infectious Diseases, Analytical Chemistry, Pharmacology, Hepatology and Parasitology, having authored 40 papers that have together received 623 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Analytical Methods in Pharmaceuticals (8 papers), Hepatitis C virus research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Toxoplasma gondii Research Studies (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), HIV-related health complications and treatments (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). The work is most often cited by research in Pharmacology (100 citations), Analytical Chemistry (116 citations), Infectious Diseases (187 citations), Emergency Medicine (57 citations) and Virology (19 citations). Peter Langmann has collaborated with scholars based in Germany and France. Frequent co-authors include Hartwig Klinker, Michael Zilly, Benedikt Weißbrich, Ralf Winzer, Steffen Desch, Franz Tollmann, Werner Heinz, Erik Arne Richter, Kathrin Kahle and Andreas Benesic. Their work appears in journals such as Infection, Journal of Chromatography B, Antimicrobial Agents and Chemotherapy, AIDS and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.